CERO THERAPEUTICS HOLDINGS, INC. Quarterly Assets in USD from Q3 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Cero Therapeutics Holdings, Inc. quarterly Assets history and growth rate from Q3 2021 to Q3 2024.
Cero Therapeutics Holdings, Inc. Assets for the quarter ending September 30, 2024 was $6.49M, a 23.4% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$6.49M	-$1.98M	-23.4%	Sep 30, 2024	10-Q/A	2024-11-20
Q2 2024	$7.37M	-$6.74M	-47.8%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$9.05M	-$5.38M	-37.3%	Mar 31, 2024	10-Q	2024-05-17
Q4 2023	$5.13M	-$37.2M	-87.9%	Dec 31, 2023	10-Q/A	2024-11-20
Q3 2023	$8.47M	-$172M	-95.3%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$14.1M	-$166M	-92.1%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$14.4M	-$165M	-92%	Mar 31, 2023	10-Q	2023-05-12
Q4 2022	$42.4M	-$138M	-76.5%	Dec 31, 2022	10-K	2024-04-02
Q3 2022	$180M	+$180M	+59851%	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$180M			Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$180M			Mar 31, 2022	10-Q	2022-05-13
Q4 2021	$180M			Dec 31, 2021	10-K	2023-03-24
Q3 2021	$301K			Sep 30, 2021	10-Q	2021-11-19

* An asterisk sign (*) next to the value indicates that the value is likely invalid.